Bulletin
Investor Alert

New York Markets Open in:

Sanofi

OTC: SNYNF

GO
/marketstate/country/us

Market closed

 --Quotes are delayed by 20 min

Dec 1, 2022, 2:14 p.m.

/zigman2/quotes/205505035/composite

$

95.30

Change

+5.05 +5.60%

Volume

Volume 1,194

Quotes are delayed by 20 min

/zigman2/quotes/205505035/composite

Previous close

$ 90.25

$ 95.30

Change

+5.05 +5.60%

Day low

Day high

$92.63

$95.30

Open

52 week low

52 week high

$73.31

$112.50

Open

Frédéric Oudéa

Currently, Frédéric Oudéa occupies the position of Chief Executive Officer & Director at Société Générale SA and Chief Executive Officer for Société Générale SA (Broker) (a subsidiary of Société Générale SA). He is also President for Fédération Bancaire Française and on the board of 5 other companies.

He previously held the position of President for European Banking Federation aisbl.

Mr. Oudéa received an undergraduate degree from Ecole Polytechnique and an undergraduate degree from Ecole Nationale d'Administration.

Transactions

Date Shares Transaction Value
09/23/2022 320   Acquisition at $78 per share. 24,960

Officers and Executives

Mr. Serge Weinberg
Chairman
Mr. Paul Hudson
Chief Executive Officer & Director
Mr. Jean-Baptiste Chasseloup de Chatillon
Chief Financial Officer & Executive Vice President
Dr. Dietmar P. Berger
Chief Medical Officer & Global Head-Development
Dr. John C. Reed
EVP & Global Head-Research & Development
Dr. Nestle Frank
Global Head-Immunology Therapeutic Research Area
Dr. Arnaud Robert
Chief Digital Officer & Executive Vice President
Ms. Julie van Ongevalle
Executive VP & Head-Consumer Healthcare
Mr. William J. Sibold
Executive Vice President-Sanofi Genzyme
Ms. Alexandra Roger
Head-Securities Law & Capital Markets
Mr. Brendan OCallaghan
Executive Vice President & Head-Industrial Affairs
Mr. Josep Catlla
Head-Communication
Mr. Raj Verma
Chief Diversity, Culture & Experience Officer
Ms. Noel M. Geoffroy
Head-North America Consumer Healthcare
Mr. Olivier Antoine M. Charmeil
Executive Vice President-General Medicines
Mr. Yann Tran
Director
Dr. Wolfgang Laux
Director
Mr. Frédéric Oudéa
Director
Mr. Christophe Babule
Director
Ms. Eva Schäfer-Jansen
Investor Relations Contact
Ms. Natalie Bickford
Chief People Officer & Executive Vice President
Ms. Claire Terrazas
Vice President-Corporate Legal Affairs
Mr. Roy Papatheodorou
General Counsel
Mr. Arnaud Delépine
Investor Relations Officer
Ms. Rachel Duan
Independent Non-Executive Director
Ms. Lise Kingo
Independent Director
Mr. Gilles Schnepp
Independent Director
Ms. Barbara Lavernos
Independent Director
Ms. Carole Gabriella Ferrand
Independent Director
Dr. Emile Voest
Independent Director
Dr. Antoine Yver
Independent Director
Ms. Fabienne Lecorvaisier
Independent Director
Mr. Patrick Kron
Independent Director
Ms. Diane D. Souza
Independent Director
Dr. Thomas C. Südhof
Independent Director
Link to MarketWatch's Slice.